Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.60    -0.025 (-4.00%)
Bid:
0.55
Ask:
0.65
Spread: 0.10 (18.182%)
Market Cap: £2.72m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Conversion of Loan Note

18 Dec 2009 13:06

RNS Number : 3955E
Physiomics PLC
18 December 2009
 



Physiomics plc

(the "Company")

Conversion of Loan Note

The Company announces that pursuant to the terms of a loan note dated 8 February 2008 and made between (i) Energiser Investments plc and (ii) the Company, (the "Loan Note"), Energiser Investments plc has requested that the full amount drawn down under the Loan Note be converted into ordinary shares in the Company.

Under the Loan Note, which was announced to the market on 15 February 2008, Energiser Investments plc (formerly Billam plc) advanced £50,000 to the Company, which is convertible into ordinary shares at a price of 0.1p per share.

The total number of shares to be issued to Energiser Investments plc, pursuant to the terms of the loan note, is therefore 50,000,000 Ordinary Shares (the "Conversion Shares")

Application has been made to admit the Conversion Shares to trading on AIM, and dealings in the Conversion Shares is expected to commence on 24 December 2009. Following the issue of the Conversion Shares, the total issued share capital of the Company will be 998,570,699 Ordinary Shares.

On 9 December 2009 it was announced that Energiser Investments plc then held 100,004 ordinary shares in the Company. Following the issue of the Conversion Shares and taking into account the holding notified on 9 December 2009, Energiser Investments plc will hold 50,100,004 Ordinary Shares in the Company, representing 5.017% of the then issued share capital. 

Enquiries:

Physiomics plc

Dr Christophe Chassagnole, COO 

+44 (0)1865 784980

WH Ireland Limited

Katy Mitchell

+44 (0161 832 2174

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGMMZFRDGLZM
Date   Source Headline
29th Apr 20154:27 pmRNSHolding(s) in Company
22nd Apr 20157:00 amRNSVirtual Tumour platform - AACR Annual Meeting 2015
26th Mar 20157:00 amRNSIssue of Options
17th Mar 20157:00 amRNSHalf Yearly Report
12th Mar 20157:00 amRNSIssue of Equity
6th Mar 20151:40 pmRNSHolding(s) in Company
4th Mar 201511:56 amRNSHolding(s) in Company
3rd Mar 201512:57 pmRNSFirst contract for clinical version of Virtu
20th Feb 201512:34 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSTermination of Equity Swap Agreement
15th Dec 20141:08 pmRNSResult of AGM
12th Nov 201410:24 amRNSFinal Results
4th Nov 20147:00 amRNSDisclosure of Large Pharma partner Merck & Co
27th Oct 201410:07 amRNSProject extension with global pharma company
13th Oct 20144:43 pmRNSHolding(s) in Company
7th Oct 20149:35 amRNSCardiotox Platform Launch
29th Aug 20142:47 pmRNSHolding(s) in Company
14th Aug 20141:10 pmRNSNew deal with global pharma
24th Jul 201412:59 pmRNSIssue of Equity
26th Jun 20147:57 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSAnticipated new collaboration with Diatech
20th May 20149:47 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSSecond validation of Virtual Tumour Clinical
14th Feb 20147:00 amRNSHalf Yearly Report
30th Jan 20144:41 pmRNSIssue of Equity - Replacement
30th Jan 20143:02 pmRNSIssue of Equity
16th Jan 20147:20 amRNSDundee University Collaboration
17th Dec 20132:07 pmRNSResult of AGM
4th Dec 201310:47 amRNSVirtual Tumour Proposal
28th Nov 20131:24 pmRNSDrugCARD launch
15th Nov 20137:00 amRNSFinal Results
11th Nov 20137:00 amRNSUniversity of Oxford Collaboration
4th Nov 20137:00 amRNSUpdate on the Virtual Tumour Clinical platform
10th Oct 201310:30 amRNSDrawdown pursuant to SEDA Arrngmnt/Issue of Equity
7th Oct 20138:32 amRNSPhysiomics gains new speciality pharma customer
1st Oct 201311:49 amRNSPhysiomics gains first large pharma customer
16th Sep 20137:00 amRNSPhysiomics to present cardiac toxicity platform
26th Jul 20131:30 pmRNSIssue of Equity
1st Jul 20137:00 amRNSAdditional SEDA Drawdown
24th Jun 20137:00 amRNSWins Poster Award
20th Jun 20134:28 pmRNSAward of Grant
11th Jun 20137:00 amRNSPopulation Approach Group Europe
6th Jun 20137:00 amRNSVirtual Tumour Clinical Contract
8th Apr 20138:03 amRNSPhysiomics to present new developments
25th Mar 20137:00 amRNSPhysiomics to provide cardiac toxicity modelling
18th Mar 20137:00 amRNSNew clinical PK/PD modelling service
13th Feb 201311:10 amRNSIssue of Options
11th Feb 20133:23 pmRNSDirector Declaration
8th Feb 20137:00 amRNSHalf Yearly Report
22nd Jan 20137:00 amRNSSEDA Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.